ArticleInternational journal of clinical pharmacy2011
A pharmacy-based private chlamydia screening programme: results from the first 2 years of screening and treatment.
Article in International journal of clinical pharmacy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A review of current practices to increase Chlamydia screening in the community--a consumer-centred social marketing perspective.Health expectations : an international journal of public participation in health care and health policy · 2016Pooled it
- Improving Access to Sexual Health Services in General Practice Using a Hub-and-Spoke Model: A Mixed-Methods Evaluation.International journal of environmental research and public health · 2022Article
- Sexual and reproductive health services provided by community pharmacists: a scoping review.BMJ open · 2021Article
- Utilisation of pharmacy-based sexual and reproductive health services: a quantitative retrospective study.Sexually transmitted infections · 2021Article
- Evaluation of a community pharmacy-led test-and-treat service for women with uncomplicated lower urinary tract infection in England.JAC-antimicrobial resistance · 2020Article
- Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience.International journal of clinical pharmacy · 2014Article
- To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia.BMJ open · 2013Article
- Emergency contraception and risk for sexually transmitted infections among U.S. women.Journal of women's health (2002) · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveA major UK Pharmacy chain private Chlamydia screening and treatment service began in October 2006. People pay for a screening kit, send off a urine sample, and are informed of their result directly. Treatment is accessed via the pharmacy chain or the National Health Service. We analysed data from the first 2 years of the service to describe the positivity rate by age and gender, profile of users and to determine if the program succeeded in reaching those who are currently being missed in other clinical settings.
settingThree hundred and thirty-eight community pharmacies from a major pharmacy chain in England and Wales.
methodsCross sectional study of the first 2 years screening and treatment data. Data was collected on number of tests, test results, age and gender. Data was also collected on treatment uptake by age and gender. Further Data regarding the treatment service including the site, was collected on customer record forms. Positivity data was analysed using χ(2).
resultsA total of 14,378 private Chlamydia screening tests were performed in pharmacies during the 2 year period. Overall positivity rates in males (9.8%) were higher than females (6.8%). The positivity rate was significantly higher in the 16-24 age group than in the 25 and over age group. A total of 533 people accessed and paid for treatment from Boots out of a total of 1,131 people who tested positive (47.1%). Hundred and thirty three (25.0%) partners also accessed treatment.
conclusionsThe data further supports the feasibility and acceptability of pharmacy testing and treatment.
Indexed as
Identifiers
21365400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.